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Abstract
Introduction
Clinical preventive services can detect diseases early, when 
they are most treatable, but these services may not be pro-
vided as recommended. Assessing the provision of services 
to patients at risk for cardiovascular disease (CVD) could 
help identify disparities and areas for improvement.
Methods
We  used  data  on  patient  visits  (n  =  21,261)  from  the 
National  Ambulatory  Medical  Care  Survey,  2005-2006, 
and classified patients with hypertension, hyperlipidemia, 
obesity, or diabetes as being at risk for CVD. We assessed 
differences in the provision of preventive services offered 
to patients who were and who were not at risk for CVD. 
Further, for those at risk, we compared the demographic 
characteristics of those who had and who had not been 
offered services.
Results
Patients  at  risk  for  CVD  received  significantly  more 
preventive  services  compared  with  those  not  at  risk. 
For patients at risk for CVD, aspirin therapy was more 
likely to be recommended to those aged 65 years or older 
than those aged 45 to 64 years and to men than women. 
Cholesterol screening was more likely for men and was less 
likely for patients with Medicare/Medicaid or no insurance 
than for patients who were insured. Rates of counseling for 
diet and nutrition, weight reduction, and exercise were low 
overall, but younger patients received these services more 
than older patients did.
Conclusion
Patients at risk for CVD are not all receiving the same 
level of preventive care, suggesting the need to clarify clin-
ical practice guidelines and provide clinicians with educa-
tion and support for more effective lifestyle counseling.
Introduction
Death rates from cardiovascular disease (CVD) have been 
falling since 1980; however, several preventable risk fac-
tors  are  increasing  (1,2).  The  rates  of  both  obesity  and 
diabetes are increasing (3,4) and may threaten the prog-
ress being made in reducing CVD mortality. Other CVD 
risk  factors  are  leveling  off  or  declining  but  still  affect 
a large proportion of the US population. Data from the 
most  recently  available  National  Health  and  Nutrition 
Examination Survey suggest that 31% of adults (20 years 
or older) have hypertension and that 16% have high serum 
cholesterol  (4).  Approximately  21%  of  US  adults  smoke 
cigarettes (5). Preventing and managing the risk factors 
for CVD are an obvious point of intervention for reducing 
disease and premature death, yet prevention is not the 
mainstay of health care in the United States, and use of 
most clinical preventive services is low (6,7).
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Clinical  preventive  services  delivered  in  the  primary 
care setting have the potential to 1) prevent risk factors 
for CVD, 2) detect risk factors and diseases early, when 
they are most treatable, and 3) treat and manage condi-
tions before they result in serious illness or in death. The 
scope of services covered by the term “clinical preventive 
services” includes screening, testing, counseling, immuni-
zation, preventive medication, and preventive treatment. 
In 2005, the Centers for Disease Control and Prevention 
partnered with the National Business Group on Health 
and the Agency for Healthcare Research and Quality to 
develop a guide for employers that described 46 clinical 
preventive services that have been determined effective 
by authoritative organizations such as the US Preventive 
Services Task Force (USPSTF) (8). A Purchaser’s Guide to 
Clinical Preventive Services: Moving Science Into Coverage 
includes descriptions of the recommended clinical services, 
a summary of the supporting evidence, and information 
about  costs  and  delivery  of  the  services  (9).  We  identi-
fied 7 clinical preventive services in the guide that were 
recommended for the prevention of CVD: aspirin therapy; 
healthy diet counseling; diabetes screening; and screening, 
counseling, and treatment for lipid disorders, hyperten-
sion, obesity and tobacco use.
The use of these services in the primary care setting has 
been documented in population-based surveys (4,10,11). 
For example, we know from 2005 Behavioral Risk Factor 
Surveillance System (BRFSS) data that 62% of smokers 
reported that they had had 1 or more visits in the past 
year at which a health professional had counseled them 
about strategies to quit smoking (12). We also know from 
population-based surveys that the rates of using preven-
tive services that involve behavioral counseling are lower 
than the rates for screening, immunization, or chemopre-
vention (13) and that there are disparities in use of pre-
ventive services by age, sex, and race (14). An alternative 
to using self-reports by survey participants is to examine 
the extent to which clinicians report providing clinical pre-
ventive services to their patients and to examine patterns 
in use by patient demographics.
We used data from the National Ambulatory Medical Care 
Survey (NAMCS) from 2005 and 2006 to assess differences 
in clinical preventive services offered to patients who were 
at risk for CVD and to those who were not at risk. For 
patients at risk for CVD, we also compared demographic 
characteristics of those who had and those who had not 
been offered the clinical preventive services.
Methods
Data sources
NAMCS is a national probability sample survey conducted 
annually by the National Center for Health Statistics. The 
survey  collects  data  on  patient  visits  to  US  nonfederal 
office-based physicians. The survey excludes physicians in 
the specialties of anesthesiology, pathology, or radiology as 
well  as  hospital  outpatient  departments  and  emergency 
departments. Before participating in the survey, physicians 
are  provided  with  reporting  forms  and  instructions  for 
completing them. Each physician is randomly assigned to 
a 1-week reporting period when data for a systematic ran-
dom sample of visits are recorded by the physician or office 
staff. Data are obtained on patients’ symptoms, physicians’ 
diagnoses, and medications ordered or provided. The survey 
also assesses the demographic characteristics of patients 
and services provided, including information on diagnostic 
procedures, patient management, and planned treatment. 
Further details of sampling design, estimates, and other 
survey information can be found at the National Center for 
Health Statistics’ website, www.cdc.gov/nchs/ahcd.htm.
In 2005 and 2006, there were 55,057 sample patient visits 
to 2,526 physicians’ offices, which represented an estimat-
ed 1.9 billion visits across the United States. The physi-
cians’ response rate was 62% in 2005 and 59% in 2006.
Study population
We  used  data  on  ambulatory  visits  to  physicians  who 
specialized in 4 types of care: general and family prac-
tice,  internal  medicine,  pediatrics,  and  cardiovascular 
diseases. We limited our analyses to visits described as a 
new problem (<3-month onset), a chronic problem (routine 
or flare-up), or preventive care. Visits for presurgery or 
postsurgery follow-up were not included. We also excluded 
patients who already had a diagnosis of CVD and women 
who were pregnant. Of 55,057 patient visits, 21,261 visits 
met our criteria and became the focus of this study.
Definition of the study variables
Patients were classified as at risk for CVD if they had at 
least 1 of the following risk factors listed as a diagnosis 
related to the visit: hypertension, hyperlipidemia, diabe-
tes, or obesity. They were also classified as at risk if the 
clinician indicated by check box that the patient had any of 
the 4 risk factors. Height and weight measurements were VOLUME 8: NO. 2
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taken at the visit, and patients with a body mass index of 
at least 30 kg/m2 were classified as obese. Patients were 
considered not at risk for CVD if they did not have any of 
the 4 risk factors. The preventive services of interest pro-
vided at each visit were captured in 4 fields in the patient 
encounter  form:  1)  diagnostic/screening  services,  which 
included  testing  for  glucose,  hemoglobin  A1c  (HbA1c), 
and  lipids/cholesterol;  2)  medications  (prescription  and 
over-the-counter), including aspirin; 3) health education, 
including  diet/nutrition,  exercise,  weight  reduction,  and 
tobacco use/exposure; and 4) vital signs, which included 
a  blood  pressure  measurement  taken  at  the  visit.  The 
clinical  services  described  as   healthy  diet  and  obesity 
screening, counseling, and treatment in the Purchaser’s 
Guide are described as diet/nutrition, exercise, and weight 
reduction in the NAMCS data set. Additional variables of 
interest that were included in the analyses were smoking 
status (current smoker vs other), sex, age, race/ethnicity, 
source of payment, and geographic region.
Statistical methods
Two-year  (2005-2006)  aggregated  data  were  used  to 
achieve  greater  power  for  this  analysis.  To  extrapolate 
our findings to national estimates, patient visit weights 
were used, and all estimates were related to the number 
of patient visits and to sample variability. Chi-square or 
Fisher exact tests were used to test for the significance 
of the associations. Multiple logistic regression analyses 
were conducted 1) to examine the associations between 
risk status for CVD (yes or no) and 8 clinical preventive 
services  adjusting  for  age,  sex,  race/ethnicity,  source 
of  payment,  region,  and  smoking  status,  and  2)  among 
patients at risk for CVD, to examine possible associations 
between patient characteristics (age, sex, race/ethnicity, 
source of payment, region, and smoking status) and each 
of the clinical preventive services. All estimates derived in 
this analysis were based on more than 30 records, and the 
relative standard error was 30% or less to comply with the 
reliability standards established by National Center for 
Health Statistics. The 2-tailed P values were significant at 
<.05. All data manipulations were done with SAS version 
9.1 (SAS, Inc, Cary, North Carolina), and all statistical 
analyses were performed with SUDAAN version 9.0 (RTI 
International, Research Triangle Park, North Carolina).
Results
Of the 21,261 patient visits included in our study, 39% of 
visits involved patients who were classified as being at 
risk for CVD (Table 1). Most patients at risk for CVD had 
hypertension (61%), followed by obesity (44%), hyperlip-
idemia  (41%),  or  diabetes  (23%).  Approximately  51%  of 
patients had only 1 risk factor, 32% had 2 risk factors, 13% 
had 3 risk factors, and 4% had all 4 risk factors. Patients 
at risk for CVD differed significantly from those not at risk 
by age, sex, race/ethnicity, source of payment, and smok-
ing status. Only regional variation was not significant.
Based on the physician reports, 97% of patients at risk for 
CVD received at least 1 of the preventive services compared 
with 63% of those not at risk. Multiple logistic regression 
analyses  showed  that  all  8  clinical  preventive  services 
were provided significantly more often at visits of patients 
at risk for CVD compared with those not at risk (Table 2). 
Aspirin therapy was prescribed or was recommended to be 
continued at 6% of visits of at-risk patients compared with 
less than 1% for those not at risk. Screening tests were 
performed more often on the at-risk patients; 95% received 
a blood pressure check, 22% had a cholesterol test, and 
18% were tested for diabetes. Education and counseling 
services were provided less often than screening services 
but were more frequent for patients at risk for CVD than 
for those not at risk. Of the counseling services, diet and 
nutrition education was offered the most frequently (26%), 
followed by exercise education (20%), and weight reduction 
education (12%). For current smokers, tobacco education 
was offered more often to patients at risk for CVD (34%) 
compared with those not at risk (25%).
To determine whether there were disparities in the pre-
ventive services offered to patients at risk for CVD, we 
examined the association between patient characteristics 
and the likelihood of services reported as provided. The 
likelihood of being prescribed aspirin or recommended to 
continue aspirin therapy was associated with age and sex 
(Table 3). Patients aged 65 years or older were more likely 
to be recommended aspirin therapy, and patients younger 
than 45 years were less likely, compared with patients 
aged  45  to  64  years.  Aspirin  therapy  was  more  likely 
to be recommended to men than women. No significant 
differences  by  patient  characteristics  were  detected  for 
diabetes screening (Table 3). Cholesterol screening, how-
ever, was significantly associated with sex and source of 
payment. Men were more likely than women to have cho-
lesterol screening, and patients with Medicare/Medicaid or   
no insurance were less likely to have cholesterol screen-
ing  than  patients  with  private  health  insurance.  Age   
and  region  of  the  country  were  the  2  characteristics   VOLUME 8: NO. 2
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significantly  associated  with  blood  pressure  screening. 
Patients younger than 35 years were less likely to have 
blood  pressure  screening  at  the  heath  care  visit  than 
patients  aged  35  to  44  years.  Patients  in  the  Midwest, 
South, and West were more likely to have a blood pressure 
screening than patients in the Northeast.
We  were  unable  to  examine  education/counseling  for 
tobacco  cessation  by  patient  characteristics  because  the 
numbers were too small; only 34% of smokers at risk for 
CVD received tobacco education (Table 2). The likelihood 
of providing education/counseling for diet/nutrition, weight 
reduction, and exercise were not associated with current 
smoking status (Table 4). Patients younger than 20 years 
received  significantly  more  diet/nutrition,  weight  reduc-
tion,  and  exercise  education  than  did  patients  aged  35 
to 44 years. Additionally, patients aged 45 years or older 
received significantly less weight-reduction education than 
did patients aged 35 to 44 years. Men were less likely than 
women to receive counseling about weight reduction and 
exercise, and Hispanic and “other” race/ethnicity patients 
were more likely to have diet/nutrition counseling than 
were  non-Hispanic  whites.  Physicians  were  less  likely 
to  report  providing  exercise  education  to  patients  with 
Medicare/Medicaid or other sources of payment than to 
privately insured patients. Patients in the South received 
significantly less diet/nutrition education compared with 
patients in the Northeast, and patients in the South and 
West were less likely to receive weight-reduction counsel-
ing compared with those in the Northeast (half as likely 
for both services).
Discussion
We  found  that  39%  of  the  patients  who  visited  physi-
cians’ offices in 2005 through 2006 who did not already 
have CVD were at risk for CVD, and 49% of those at risk 
for CVD had more than 1 of 4 risk factors. As might be 
expected, more clinical preventive services were provided 
to at-risk patients compared with patients not at risk for 
CVD.
At-risk  patients  were  treated  differently  according  to 
demographic and patient characteristics. Physicians were 
more  likely  to  report  prescribing  or  recommending  the 
continuation of aspirin therapy to patients who were men 
and were aged 65 years or older. In 2002, USPSTF recom-
mended that clinicians discuss aspirin therapy with adults 
who are at risk for coronary heart disease (CHD). Further, 
they suggested that the balance of benefits and risks was 
most favorable in patients at high risk for CHD (those 
with a 5-year risk ≥3%) (15). USPSTF recently revised its 
recommendations on aspirin use for prevention of CVD, 
limiting the ages to men aged 45 to 79 years and to women 
aged 55 to 79 years and taking both age and 10-year risk 
into consideration, balancing cardiovascular benefit with 
risk  for  gastrointestinal  hemorrhage  (16).  Although  the 
update to this recommendation was not published until 
2009, providers in our study reported prescribing aspirin 
more frequently for men, which is more consistent with 
the new recommendation than with the recommendation 
that was current at the time of data collection.
Guidelines for when screening should start, frequency of 
screening, and special considerations for people at high 
risk for diabetes, lipid disorders, and hypertension vary 
according to age (17-24). Women in our study were less 
likely than men to receive cholesterol screening. This find-
ing may be partly attributable to clinicians following the 
USPSTF guideline for lipid screening, which recommends 
routine screening for men from age 35 but only recom-
mends screening for women aged 20 to 45 years who are 
at  increased  risk  for  CHD  (19).  Another  guideline,  the 
National Cholesterol Education Program Adult Treatment 
Expert  Panel  III,  recommends  routine  blood  cholesterol 
screening of all adults aged 20 years or older every 5 years 
(20). Patients with Medicare/Medicaid or with no insur-
ance were also less likely to receive cholesterol screening 
than were patients with private insurance. Out-of-pocket 
cost to patients or differences in covered services by pub-
lic-sector payers, or both, may be among the reasons for 
these differences. Patients younger than 35 years received 
blood  pressure  screening  at  their  visits  less  often  than 
did patients aged 35 to 44 years. USPSTF recommends 
that clinicians screen all adults aged 18 years or older for 
hypertension but does not recommend a specific screening 
interval (21). Many professional organizations, including 
the American Academy of Pediatrics and the American 
Heart Association, recommend that everyone aged 3 years 
or older have their blood pressure measured during every 
health care visit (24). Given that hypertension in youth is 
being diagnosed with increasing frequency (25) and that 
controlling blood pressure is one of the most cost-effective 
methods of reducing premature CVD (26), blood pressure 
screening for people of all ages should be routine.
We  found  lower  rates  of  educational  services  for  older 
adults (aged ≥65 y) for all 3 lifestyle interventions, although 
the  weight-reduction  counseling  was  the  only  one  that VOLUME 8: NO. 2
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was significant. Patients younger than 20 years received 
significantly  more  diet/nutrition,  weight-reduction,  and 
exercise education than did patients aged 35 to 44 years. 
Recommendations  for  lifestyle  education  or  counseling 
in the clinical setting do not vary by age, although many 
guidelines recommend that sedentary middle-aged or older 
adults consult a physician before starting a new exercise 
program (21,22). The age discrepancy in weight-reduction 
education may indicate that providers believe older adults 
are not as willing to change behavior or are less likely to 
succeed at changing behavior. Older adults may also have 
been less likely than younger adults to be overweight or 
to have had more serious health problems for clinicians to 
address during the visit. We also found that Hispanic and 
other race/ethnicity groups were more likely to receive diet 
or nutrition education than were non-Hispanic whites and 
that men were less likely than women to receive weight-
reduction  and  exercise  education.  Other  large  surveys 
have found that women received exercise counseling more 
frequently than did men (27,28). The most recent BRFSS 
data show that men are more likely than women to report 
meeting Healthy People 2010 physical activity guidelines 
(52% vs 48%, respectively) (29). If men are already exercis-
ing more than women, it could account for the differences 
seen in exercise counseling in our study. Despite national 
guidelines for lifestyle counseling in the primary care set-
ting, barriers limit its use, such as time, skills, reimburse-
ment, coverage of services by insurance companies, and 
perceived effectiveness of lifestyle counseling (30). Another 
challenge  is  the  multiplicity  of  independent  guidelines 
from different organizations for physicians to follow. To 
overcome some of these barriers, health care providers can 
refer patients to community programs, such as wellness 
classes, fitness facilities, and programs offered by health 
plans, employers, or public health departments, for more 
intensive counseling (6).
This study has several limitations. First, as noted above, 
the data were collected per visit, not per patient. It was not 
possible to determine whether patients were eligible for 
screening tests at the visit, and most tests are not recom-
mended at every visit. Diabetes screening, for example, is 
recommended only every 2 years for people at increased 
risk (17). Another limitation was the cross-sectional study 
design, which did not allow us to determine when the risk 
for CVD began. Additionally, the encounter form used to 
collect the data had little detail about the specific services 
provided, such as the type and intensity of the educational 
sessions. Lastly, since the data were reported by providers 
themselves or obtained from the providers’ notes in the 
medical record, there may be some bias toward overre-
porting, because of either expectations or reimbursement 
concerns.
This  study  suggests  that  physicians  are  accounting  for 
CVD risk factors and that they are providing some pre-
ventive services to most at-risk patients. However, it also 
identifies disparities between some subgroups in the popu-
lations of at-risk patients who are not receiving the same 
level  of  preventive  care.  It  may  be  necessary  to  clarify 
practice guidelines and to specify that lifestyle interven-
tions are appropriate and effective for all ages. Physicians 
also may require more education and support for effective 
lifestyle  counseling.  And  finally,  since  the  impetus  for 
this study was A Purchaser’s Guide to Clinical Preventive 
Services:  Moving  Science  Into  Coverage  (9),  it  would  be 
beneficial to know whether the guide is having an effect on 
the provision of services or on coverage for these services.
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Tables
Table 1. Proportion of Patients at Risk for Cardiovascular Disease, by Patient Characteristics, National Ambulatory Medical Care 
Survey, 2005-2006
Characteristic No. (%), N = 21,261 At Risk for CVD,a Weighted % (SE) P Valueb
Total 21,21 9.2 (1.) NA
Age, y
<20 ,189 (4) 4.2 (0.4)
<.001
20-4 2,244 (11) 29.4 (1.)
-44 2,9 (11) 44.1 (1.)
4-4 ,40 (2) 2. (1.)
≥65 ,91 (18) . (2.0)
Sex
Female 11,8 () 40.8 (1.4)
<.001
Male 9,48 (4) .2 (1.4)
Race/ethnicity
Non-Hispanic white 14,19 () 9.9 (1.)
.00
Non-Hispanic black 2,88 (11) 4. (.2)
Hispanic ,12 (1) 1.8 (2.1)
Other 1,82 () 8.0 (.)
 
Abbreviations: CVD, cardiovascular disease; SE, standard error; NA, not applicable. 
a Risk defined as having hypertension, hyperlipidemia, obesity, or diabetes.  
b Calculated by using χ2 test. 
c Northeast: Connecticut, Maine, Massachusetts, New Hampshire, New Jersey, New York, Pennsylvania, Rhode Island, Vermont; Midwest: Illinois, Indiana, Iowa, 
Kansas, Michigan, Minnesota, Missouri, Nebraska, North Dakota, Ohio, South Dakota, Wisconsin; South: Alabama, Arkansas, Delaware, District of Columbia, 
Florida, Georgia, Kentucky, Louisiana, Maryland, Mississippi, North Carolina, Oklahoma, South Carolina, Tennessee, Texas, Virginia, West Virginia; West: Alaska, 
Arizona, California, Colorado, Hawaii, Idaho, Montana, Nevada, New Mexico, Oregon, Utah, Washington, Wyoming.
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Table 2. Likelihood of Clinical Preventive Services Being Provided to Patients at Risk for Cardiovascular Disease Compared With 
Those Not at Risk, National Ambulatory Medical Care Survey, 2005-2006
Service
At Risk for CVD, Weighted % (SE)
Adjusted ORa (95% CI) Yes No
Aspirin prescribed or continued .0 (0.) 0. (0.1) . (2.-.0)
Diabetes screening 18.4 (1.0) .9 (0.4) .2 (2.-4.0)
Lipid/cholesterol test 21.9 (1.0) 4.4 (0.4) .0 (2.-.)
Blood pressure screening 9.0 (0.) 4. (1.) .9 (.1-4.8)
Diet/nutrition education 2. (1.) 14.9 (1.) 4.0 (.-4.8)
Weight reduction education 11. (0.8) 1.0 (0.2) 1.9 (11.0-2.0)
Exercise education 19. (1.) . (0.8) . (2.-4.0)
Tobacco education (current smokers only) . (2.) 24.8 (2.4) 1. (1.1-2.0)
 
Abbreviations: CVD, cardiovascular disease; SE, standard error; OR, odds ratio; CI, confidence interval. 
a Data were adjusted for age, sex, race/ethnicity, source of payment, region, and smoking status except for tobacco education. Tobacco education for current 
smokers was assessed only after adjusting for age, sex, race/ethnicity, source of payment, and region. Eight clinical preventive services were assessed with 
the outcome (risk for CVD) independently by using multiple logistic regression models. All values were significant at P < .01.
Characteristic No. (%), N = 21,261 At Risk for CVD,a Weighted % (SE) P Valueb
Source of payment
Private insurance 10,48 (49) 4.2 (1.)
<.001
Medicare/Medicaid ,414 () 48.8 (2.0)
No insurance 1,11 () 8.0 (.)
Other 2,20 (11) . (2.4)
Regionc
Northeast 4,90 (2) .1 (2.2)
.1
Midwest 4,844 (2) 42.8 (.4)
South ,8 (2) 40. (2.1)
West 4,89 (2) . (2.4)
Smoking status
Current 2,224 (11) 0.4 (1.4)
<.001
Other 19,0 (90) 8.0 (1.4)
 
Abbreviations: CVD, cardiovascular disease; SE, standard error; NA, not applicable. 
a Risk defined as having hypertension, hyperlipidemia, obesity, or diabetes.  
b Calculated by using χ2 test. 
c Northeast: Connecticut, Maine, Massachusetts, New Hampshire, New Jersey, New York, Pennsylvania, Rhode Island, Vermont; Midwest: Illinois, Indiana, Iowa, 
Kansas, Michigan, Minnesota, Missouri, Nebraska, North Dakota, Ohio, South Dakota, Wisconsin; South: Alabama, Arkansas, Delaware, District of Columbia, 
Florida, Georgia, Kentucky, Louisiana, Maryland, Mississippi, North Carolina, Oklahoma, South Carolina, Tennessee, Texas, Virginia, West Virginia; West: Alaska, 
Arizona, California, Colorado, Hawaii, Idaho, Montana, Nevada, New Mexico, Oregon, Utah, Washington, Wyoming.
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Table 3. Likelihood of Clinical Preventive Services Being Provided, by Patient Characteristic for Patients at Risk for Cardiovascular 
Disease, National Ambulatory Medical Care Survey, 2005-2006
Characteristic
Aspirin Recommended Diabetes Screening Cholesterol Screening Blood Pressure Screening
% (SE)
Adjusted ORa 
(95% CI) % (SE)
Adjusted ORa 
(95% CI) % (SE)
Adjusted ORa 
(95% CI) % (SE)
Adjusted ORa 
(95% CI)
Total .0 (0.) NA 18.4 (1.0) NA 21.9 (1.0) NA 9.0 (0.) NA
Age, y
<20 0. (0.)
0.2 (0.1-0.4)b
12.8 (.) 0. (0.4-1.) 1.2 (2.) 0. (0.4-1.0) 4. (.)
0.4 (0.2-0.)b
20-4 1.2 (0.) 12.1 (1.) 0. (0.-1.0) 1. (2.0) 0. (0.-1.0) 9.4 (1.)
-44 1.8 (0.) 1.9 (1.8) 1 [Reference] 21. (1.9) 1 [Reference] 9. (1.0) 1 [Reference]
4-4 .8 (0.9) 1 [Reference] 19. (1.) 1.2 (0.9-1.) 24.0 (1.2) 1.1 (0.9-1.4) 9.1 (0.) 1.2 (0.8-1.9)
≥65 9.4 (1.0) 2.0 (1.4-2.8)b 19. (1.4) 1.2 (0.9-1.) 21. (1.4) 1.1 (0.9-1.) 9.1 (0.) 1.4 (0.9-2.)
Sex
Women .4 (0.) 1 [Reference] 1.4 (1.2) 1 [Reference] 20. (1.2) 1 [Reference] 94.9 (0.) 1 [Reference]
Men .8 (0.9) 1.4 (1.1-1.8)b 19. (1.2) 1.2 (0.99-1.4) 2. (1.2) 1.2 (1.0-1.4)b 9.2 (0.) 1.1 (0.8-1.4)
Race/ethnicity
Non-Hispanic 
white
. (0.) 1 [Reference] 18.1 (1.2) 1 [Reference] 22. (1.1) 1 [Reference] 9.1 (0.) 1 [Reference]
Non-Hispanic 
black
4. (1.0) 0.8 (0.-1.) 1. (2.1) 1.1 (0.8-1.) 19. (2.) 0.9 (0.-1.2) 9.0 (1.0) 1. (0.8-2.1)
Hispanic 4.2 (0.9) 0. (0.4-1.2) 20. (2.) 1.2 (0.9-1.) 20. (2.) 1.0 (0.-1.) 94.1 (1.2) 0.9 (0.-1.)
Other 8. (.) 1.4 (0.-.) 19.1 (2.9) 1.0 (0.-1.) 18.9 (2.8) 0.9 (0.-1.) 94. (2.9) 0.8 (0.-2.2)
Source of payment
Private insurance .2 (0.8) 1 [Reference] 18. (1.2) 1 [Reference] 2.9 (1.1) 1 [Reference] 9.1 (0.) 1 [Reference]
Medicare/
Medicaid
. (0.9) 0.8 (0.-1.1) 18.9 (1.4) 1.0 (0.8-1.) 20.2 (1.4) 0.8 (0.-0.98)b 9.2 (0.) 0.8 (0.-1.2)
No insurance
4.2 (0.9) 0.8 (0.-1.)
1.1 (2.) 0.9 (0.-1.) 1. (.1) 0. (0.4-0.99)b
94.1 (1.4) 0.8 (0.4-1.)
Other 1.2 (2.4) 0.9 (0.-1.) 20.1 (2.4) 0.8 (0.-1.1)
Region
Northeast .0 (1.) 1 [Reference] 21. (2.) 1 [Reference] 24. (2.0) 1 [Reference] 89. (1.8) 1 [Reference]
Midwest . (1.2) 1. (0.-2.) 18.8 (1.8) 0.9 (0.-1.2) 22.4 (2.0) 0.9 (0.-1.2) 9.1 (0.8) .0 (1.-.2)b
South .9 (1.1) 1. (0.-2.) 1.4 (1.) 0. (0.-1.1) 21. (1.) 0.9 (0.-1.2) 9. (0.) .4 (1.9-.9)b
West . (1.9) 1. (0.-.2) 19.1 (2.0) 0.9 (0.-1.2) 19. (1.8) 0.8 (0.-1.1) 9. (1.) 2. (1.4-4.8)b
Smoking status
Current 4. (0.9) 0.8 (0.-1.2) 1.0 (1.8) 0.9 (0.-1.2) 20.8 (1.9) 0.9 (0.-1.1) 9.1 (1.2) 1.0 (0.-1.)
Other .2 (0.) 1 [Reference] 18. (1.1) 1 [Reference] 22.0 (1.0) 1 [Reference] 9.0 (0.) 1 [Reference]
 
Abbreviations: SE, standard error; OR, odds ratio; CI, confidence interval; NA, not applicable. 
a The ORs for each variable were adjusted for all other variables listed in the table. The groups for age and source of payment were collapsed for modeling 
aspirin and blood pressure screening to comply with National Center for Health Statistics criteria. 
b Significant at P < .05. Calculated by using χ2 test.VOLUME 8: NO. 2
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Table 4. Likelihood of Education and Counseling Being Provided, by Patient Characteristics for Patients at Risk for Cardiovascular 
Disease, National Ambulatory Medical Care Survey, 2005-2006
Characteristic
Diet/Nutrition Education Weight-Reduction Education Exercise Education
% (SE)
Adjusted ORa 
(95% CI) % (SE)
Adjusted ORa 
(95% CI) % (SE)
Adjusted ORa 
(95% CI)
Total 2. (1.) NA 11. (0.8) NA 19. (1.) NA
Age, y
<20 4.4 (4.) 1.9 (1.2-2.8)b 2.4 (4.) 1.8 (1.1-.0)b 28. (4.) 1. (1.1-2.4)b
20-4 2.4 (2.8) 0.9 (0.-1.2) 18. (2.4) 1.1 (0.-1.) 21. (2.8) 1.1 (0.8-1.)
-44 28.9 (2.) 1 [Reference] 1.4 (2.0) 1 [Reference] 20. (2.4) 1 [Reference]
4-4 2.1 (1.8) 0.9 (0.-1.2) 12.0 (1.0) 0. (0.-0.8)b 21.4 (1.8) 1.0 (0.8-1.)
≥65 22. (1.9) 0.8 (0.-1.1) .9 (0.) 0. (0.2-0.)b 1.9 (1.) 0.9 (0.-1.2)
Sex
Women 2.8 (1.) 1 [Reference] 12.2 (1.0) 1 [Reference] 20.4 (1.) 1 [Reference]
Men 2. (1.) 0.9 (0.8-1.0) 10.9 (0.9) 0.8 (0.-0.99)b 18. (1.) 0.8 (0.-0.9)b
Race/ethnicity
Non-Hispanic white 24. (1.) 1 [Reference] 11. (0.9) 1 [Reference] 19.2 (1.) 1 [Reference]
Non-Hispanic black 2. (2.) 1.2 (0.9-1.) 11.8 (1.) 1.0 (0.-1.) 18.0 (2.) 0.9 (0.-1.)
Hispanic 2.1 (4.) 1. (1.04-2.1)b 12.8 (1.8) 1.1 (0.8-1.) 2.0 (4.2) 1.2 (0.9-1.8)
Other 4. (.9) 1. (1.1-2.)b 10.2 (2.) 1.1 (0.-1.8) 2. (4.4) 1. (0.8-2.1)
Source of payment
Private insurance 28. (1.8) 1 [Reference] 14.2 (1.2) 1 [Reference] 22. (1.) 1 [Reference]
Medicare/Medicaid 2.2 (1.8) 0.8 (0.-1.0) 8.1 (0.9) 0.9 (0.-1.2) 1.4 (1.8) 0. (0.-0.9)b
No insurance 29.8 (4.8) 1.1 (0.-1.) 1.2 (4.) 1.1 (0.-2.1) 24. (.) 1.2 (0.-2.1)
Other 2. (.) 0.9 (0.-1.) 11. (2.1) 0.8 (0.-1.) 1.0 (2.) 0. (0.4-0.9)b
Region
Northeast .9 (.) 1 [Reference] 1.8 (2.2) 1 [Reference] 2.2 (.8) 1 [Reference]
Midwest 2.4 (2.) 0. (0.-1.1) 1. (1.8) 0.8 (0.-1.2) 1.9 (2.2) 0. (0.4-1.0)
South 22.1 (2.) 0. (0.4-0.9)b 9. (1.2) 0. (0.-0.8)b 1. (2.) 0. (0.4-1.0)
West 2. (.) 0. (0.4-1.1) 9.1 (1.4) 0. (0.-0.8)b 21. (.8) 0.8 (0.4-1.4)
Smoking status
Current 24.9 (2.) 1.0 (0.8-1.2) 10. (1.) 0.8 (0.-1.1) 20. (2.8) 1.1 (0.8-1.)
Other 2. (1.) 1 [Reference] 11.8 (0.9) 1 [Reference] 19. (1.) 1 [Reference]
 
Abbreviations: SE, standard error; OR, odds ratio; CI, confidence interval; NA, not applicable. 
a The ORs for each variable were adjusted for all other variables listed in the table. 
b Significant at P < .0. Calculated by using χ2 test.